Table 1 Comparison of demographic characteristics of patients with COVID-19 in two groups (hypertensive and normotensive patients)
Variable | hypertensive (N: 176) | Non-hypertensive (N:422) | P-value |
|---|---|---|---|
Age (Year) | 58.21 ± 22.5 | 56.15 ± 20.2 | 0.18 |
BMI (kg/m2) | 28.62 ± 4.6 | 28.01 ± 4.3 | 0.13 |
Sex (male) | 115(65.3%) | 289(68.5%) | 0.78 |
Education | 0.65 | ||
• < diploma | 57 (32.4%) | 111(26.3%) | |
• >Diploma | 119(67.6%) | 311 (73.7%) | |
Exposure history | 30(17%) | 191 (45.2%) | 0.45 |
• Contact with patients | 118(67%) | 250 (59.2%) | 0.061 |
• Go hospital | 30(17%) | 87(20.6%) | 0.23 |
• Public transportation | 24(22.5%) | 118(24.1%) | 0.64 |
Comorbidities (positive) | 108(61.3%) | 249(59%) | 0.75 |
Current smoker | 4(2.2%) | 12(2.8%) | 0.92 |
Diabetes | 72(40.9%) | 76(18%) | 0.001 |
CVD | 63(35.7%) | 44(10.3%) | 0.001 |
MI | 4(2.3%) | 2(0. 5%) | 0.061 |
Lung diseases | 36(20.4%) | 52(12.3%) | 0.07 |
Asthma and Allergy | 31(17.6%) | 67 (15.9%) | 0.45 |
Kidney diseases | 25(14.3%) | 33(7.8%) | 0.013 |
Liver diseases | 10(5.7%) | 22(5.2%) | 0.47 |
Cancer | 4(2.3%) | 8(1.9%) | 0.68 |
Blood Group | |||
• A | 55(31.3%) | 139(32.8%) | 0.21 |
• B | 45(25.5%) | 110(26.3%) | 0.71 |
• AB | 21(11.9%) | 60(14.2%) | 0.52 |
• O | 55(31.3%) | 113(26.7%) | 0.31 |
Clinical type of COVID- 19 infection on admission | |||
Severe/Critical type (%) | 42(23.8%) | 41(9.7%) | 0.012 |